big pharma News

Technical Expertise, Potential for Time and Cost Savings Underlines Viability of Contract Outsourcing

New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD

New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

View IPR’s Most Recent Report Titles from the 2011 Catalog and Our Newly Launched Insight Update Series.

New Report Finds Global Biotechnology Industry Poised for Massive 5-Year Growth

The inability of the medical profession to actually think about what they are doing when they prescribe medications is highlighted by a new study warning that much of the blood pressure medication given may actually be making blood pressure worse.

While this report looks at the entire Phama R&D pipeline to 2015, a key focus is the increasing role of biopharmaceutical products.

A ‘Top 10’ pharmaceutical company is one of the first to implement Debra 5.7.7, the latest release of LabLogic Systems’ LIMS for drug metabolism studies.

A nightmarish story of two week old twins of Dennis Quaid and Kimberley Buffington, getting overdosed by a 1000 times overdose of blood thinner Heparin* at LA Cedars Sinai Hospital (*already under scrutiny for Chinese manufacturing contamination)